Biotech Values

[rfj1862]

>You've got to believe that some of the hedge fund crisis will spill over into small-cap biotech. That coupled with tax-loss selling could make for a brutal September/October, unless the FED comes to the rescue.<

It's just as likely that any hedge-fund crisis would benefit small cap biotechs. The vast majority of hedge funds are short, not long, on biotech.

And I'd like to see hedge fund managers' heads served on a plate to their investors. The growth of the hedge fund industry is a relatively recent phenomenon, the market got along without them just fine before and will after a significant percentage of them are put out of business. As far as I'm concerned, most of 'em are just blood-sucking ticks.